1979
DOI: 10.1038/bjc.1979.189
|View full text |Cite
|
Sign up to set email alerts
|

Timing of indomethacin in the control of prostaglandins, osteoclasts and bone destruction produced by VX2 carcinoma in rabbits

Abstract: Summary.-Rabbits were injected with VX2 cancer cells into the left thigh or tibia, and given indomethacin 1-16 mg/kg daily starting on the day before tumour implantation or 7, 14 or 21 days after implantation. Indomethacin at 2 mg/kg and above from before tumour implantation reduced osteoclast proliferation and the amount of prostaglandin-like material extracted from homogenates of excised tumours, but the inhibition of bone destruction in vivo was significant only with indomethacin at 4 mg/kg and above. Indom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
13
0

Year Published

1980
1980
2003
2003

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(13 citation statements)
references
References 9 publications
0
13
0
Order By: Relevance
“…Carcinogens or transplantable tumors have been used in experimental bone invasion models of oral carcinoma (7,19,(23)(24)(25). Carcinogens such as 9,10-dimethyl 1,2-benzanthracene (DMBA) and 4-nitroquinoline N-oxide (4-NQO) are often used to experimentally induce carcinoma (7,25).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Carcinogens or transplantable tumors have been used in experimental bone invasion models of oral carcinoma (7,19,(23)(24)(25). Carcinogens such as 9,10-dimethyl 1,2-benzanthracene (DMBA) and 4-nitroquinoline N-oxide (4-NQO) are often used to experimentally induce carcinoma (7,25).…”
Section: Discussionmentioning
confidence: 99%
“…However, they all have shortcomings, such as complex preparation procedures, and such carcinogens require a long duration for establishment of an animal model, making it difficult to obtain a standardized model. Many studies on tumor invasion using a transplantable tumor, such as mouse NR-S1 tumor (19), VX2 tumor (23), and VX7 tumor (24), have been reported. To make an experimental model for gingival carcinoma invading bone tissue, a piece of tumor was transplanted directly into the extraction socket in the present study.…”
Section: Discussionmentioning
confidence: 99%
“…Prostaglandins, particularly PGE, are potent bone resorption agents in vitro (Dietrich et al 1975). The role of prostaglandins in certain states of pathologic bone resorption is supported by the bone mass sparing effect of nonsteroidal anti-inflammatory drug (NSAID) treatment of cancer metastases (Powles et al 1973, Galasko et al 1979, osteomyelitis Francis 1981, Rissing andBuxton 1986), and periodontal disease (Williams et al 1985). In experimental osteomyelitis, reduction in bone PGE was associated with decreased bone destruction in rabbits treated with sodium salicylate or ibuprofen (Rissing and Buxton 1986).…”
Section: Discussionmentioning
confidence: 99%
“…The E series prostaglandins are known to be potent bone resorption agents (Dietrich et al 1975), and large quantities of prostaglandin E2 are produced by bone in culture (Raisz et al 1979). Furthermore, treatment with inhibitors of prostaglandin synthesis has been associated with bone mass sparing in certain states of pathologic bone resorption, including cancer metastases (Powles et al 1973, Galasko et al 1979, osteomyelitis Francis 1981, Rissing andBuxton 1986), and periodontal disease (Williams et al 1985). Aspirin (acetylsalicylic acid) inhibits prostaglandin synthesis via irreversible acetylation of cyclooxygenase, the enzyme that converts arachidonic acid to prostaglandin endoperoxides (Higgs et al 1984, Clissold 1986).…”
mentioning
confidence: 99%
“…Both indomethacin and dichloromethane diphosphonate [C12C(PO3H2)2] reduce the bone calcium resorption produced by VX2 rabbit carcinoma in vitro (4,6) and the former is also effective in vivo (7). Cl2C(P03H2)2 is a potent inhibitor of osteoclastic bone resorption in vitro and in vivo (8,9).…”
mentioning
confidence: 99%